Pressure BioSciences, Inc. (PBIO)
Chart Events
Performance Outlook
| Previous Close | 1.7000 |
| Open | 1.7199 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.6850 - 1.7300 |
| 52 Week Range | 1.5800 - 4.9800 |
| Volume | |
| Avg. Volume | 20,893 |
| Market Cap | 15.073M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PBIO
Related Research
- PRESSURE BIOSCIENCES INCAnalyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.RatingFair ValueEconomic MoatyesterdayArgus Research
- ACCESSWIRE
Pressure BioSciences, Inc. Reports Q1 2022 Financial Results
Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and CosmeticsInvestor Call Scheduled for Thursday, May 19, 2022 at 4:30 p. ETSOUTH EASTON, MA / ACCESSWIRE / May 19, 2022 / Pressure BioSciences, Inc.
- ACCESSWIRE
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain ReductionSOUTH EASTON, MA / ACCESSWIRE / May 4, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agr
- ACCESSWIRE
Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022
Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDTSOUTH EASTON, MA / ACCESSWIRE / May 3, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, today an
